27.70
price down icon0.75%   -0.21
 
loading
Precedente Chiudi:
$27.91
Aprire:
$28.13
Volume 24 ore:
1.85M
Relative Volume:
1.13
Capitalizzazione di mercato:
$4.72B
Reddito:
$1.51B
Utile/perdita netta:
$333.35M
Rapporto P/E:
22.34
EPS:
1.24
Flusso di cassa netto:
$315.22M
1 W Prestazione:
-2.29%
1M Prestazione:
-0.04%
6M Prestazione:
+13.80%
1 anno Prestazione:
+16.58%
Intervallo 1D:
Value
$27.49
$28.18
Intervallo di 1 settimana:
Value
$27.11
$28.47
Portata 52W:
Value
$22.22
$32.88

Alkermes Plc Stock (ALKS) Company Profile

Name
Nome
Alkermes Plc
Name
Telefono
00-353-1-772-8000
Name
Indirizzo
CONNAUGHT HOUSE, DUBLIN 4
Name
Dipendente
2,100
Name
Cinguettio
@alkermes
Name
Prossima data di guadagno
2024-10-24
Name
Ultimi documenti SEC
Name
ALKS's Discussions on Twitter

Confronta ALKS con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
ALKS 27.70 4.72B 1.51B 333.35M 315.22M 1.24
ZTS 176.71 79.55B 9.15B 2.43B 2.31B 4.92
HLN 9.55 43.18B 14.26B 1.55B 0 0.3327
TAK 13.33 42.26B 30.27B 1.93B 3.45B 0.444
TEVA 17.08 19.35B 16.77B -959.00M 1.37B -2.00
VTRS 13.25 15.77B 15.24B -646.50M 1.88B 1.53

Alkermes Plc Stock (ALKS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2023-11-20 Ripresa JP Morgan Neutral
2023-10-24 Aggiornamento Evercore ISI In-line → Outperform
2023-10-17 Iniziato UBS Neutral
2022-11-03 Aggiornamento Piper Sandler Neutral → Overweight
2022-10-14 Aggiornamento BofA Securities Underperform → Neutral
2022-08-16 Iniziato Piper Sandler Neutral
2022-04-22 Ripresa Goldman Buy
2022-04-20 Iniziato Goldman Buy
2022-01-27 Aggiornamento Cantor Fitzgerald Hold → Overweight
2021-12-01 Iniziato Citigroup Neutral
2021-10-07 Aggiornamento Jefferies Hold → Buy
2021-09-02 Downgrade BofA Securities Neutral → Underperform
2020-10-15 Aggiornamento Mizuho Neutral → Buy
2020-07-30 Downgrade Goldman Neutral → Sell
2020-02-14 Downgrade BofA/Merrill Buy → Neutral
2020-02-14 Reiterato H.C. Wainwright Neutral
2020-02-14 Downgrade JP Morgan Overweight → Neutral
2020-02-06 Iniziato Mizuho Neutral
2020-01-31 Aggiornamento Wolfe Research Underperform → Peer Perform
2019-09-05 Aggiornamento Morgan Stanley Underweight → Equal-Weight
2019-07-15 Aggiornamento Goldman Sell → Neutral
2019-05-31 Iniziato H.C. Wainwright Neutral
2019-05-01 Downgrade Citigroup Buy → Neutral
2018-12-19 Downgrade Goldman Neutral → Sell
2018-12-14 Iniziato Wolfe Research Underperform
2018-12-13 Downgrade Credit Suisse Outperform → Underperform
2018-11-05 Iniziato Piper Jaffray Neutral
2018-08-07 Iniziato Stifel Hold
2018-06-21 Downgrade Morgan Stanley Equal-Weight → Underweight
2018-06-06 Iniziato B. Riley FBR, Inc. Buy
2018-05-16 Aggiornamento Citigroup Neutral → Buy
2018-05-11 Iniziato BofA/Merrill Buy
Mostra tutto

Alkermes Plc Borsa (ALKS) Ultime notizie

pulisher
Nov 21, 2024

Are Options Traders Betting on a Big Move in Alkermes (ALKS) Stock? - Yahoo Finance

Nov 21, 2024
pulisher
Nov 21, 2024

(ALKS) Trading Report - Stock Traders Daily

Nov 21, 2024
pulisher
Nov 20, 2024

Alkermes (NASDAQ:ALKS) pulls back 6.0% this week, but still delivers shareholders respectable 5.8% CAGR over 5 years - Simply Wall St

Nov 20, 2024
pulisher
Nov 20, 2024

Alkermes plc (NASDAQ:ALKS) Stock Position Decreased by Segall Bryant & Hamill LLC - MarketBeat

Nov 20, 2024
pulisher
Nov 20, 2024

Substance Abuse Treatment Market Expected to Reach High Growth by 2031: Allergan PLC, Alkermes, Noramco. - openPR

Nov 20, 2024
pulisher
Nov 20, 2024

Royce & Associates LP Grows Stock Holdings in Alkermes plc (NASDAQ:ALKS) - MarketBeat

Nov 20, 2024
pulisher
Nov 19, 2024

Alkermes plc (NASDAQ:ALKS) Shares Purchased by AMG National Trust Bank - MarketBeat

Nov 19, 2024
pulisher
Nov 16, 2024

Brokerages Set Alkermes plc (NASDAQ:ALKS) PT at $35.42 - MarketBeat

Nov 16, 2024
pulisher
Nov 13, 2024

Alkermes (NASDAQ:ALKS) Price Target Raised to $40.00 at Mizuho - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

Alkermes plc (NASDAQ:ALKS) Shares Sold by Principal Financial Group Inc. - MarketBeat

Nov 13, 2024
pulisher
Nov 11, 2024

Alkermes to Participate in Two Upcoming Investor Conferences - Lelezard

Nov 11, 2024
pulisher
Nov 11, 2024

Alkermes (ALKS) to Present at Major Healthcare Conferences: Stifel and Jefferies London | ALKS Stock News - StockTitan

Nov 11, 2024
pulisher
Nov 10, 2024

Trend Tracker for (ALKS) - Stock Traders Daily

Nov 10, 2024
pulisher
Nov 10, 2024

Alkermes plc (NASDAQ:ALKS) Shares Purchased by Robeco Institutional Asset Management B.V. - MarketBeat

Nov 10, 2024
pulisher
Nov 10, 2024

Van ECK Associates Corp Purchases 29,998 Shares of Alkermes plc (NASDAQ:ALKS) - MarketBeat

Nov 10, 2024
pulisher
Nov 08, 2024

Wellington Management Group LLP Adjusts Stake in Alkermes PLC - GuruFocus.com

Nov 08, 2024
pulisher
Nov 07, 2024

Narcolepsy Insights from Alkermes Presented at Psych Congress and NEI Congress - Sleep Review

Nov 07, 2024
pulisher
Nov 07, 2024

Alkermes Highlights Presentations From Across Neuroscience Portfolio at Key Fall 2024 Scientific Conferences - Chicago Star Media

Nov 07, 2024
pulisher
Nov 07, 2024

Alkermes EVP Craig Hopkinson sells $309,168 in stock - Investing.com

Nov 07, 2024
pulisher
Nov 07, 2024

Alkermes EVP Craig Hopkinson sells $309,168 in stock By Investing.com - Investing.com Australia

Nov 07, 2024
pulisher
Nov 06, 2024

Insider Sale at Alkermes PLC: EVP R&D, Chief Medical Officer Cra - GuruFocus.com

Nov 06, 2024
pulisher
Nov 06, 2024

Alkermes raised to buy by Stifel on increased confidence for ALKS2680 - MSN

Nov 06, 2024
pulisher
Nov 05, 2024

Alkermes to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference - GuruFocus.com

Nov 05, 2024
pulisher
Nov 05, 2024

Vanguard Group Inc's Recent Transaction in Alkermes PLC Shares - GuruFocus.com

Nov 05, 2024
pulisher
Nov 05, 2024

Alkermes (NASDAQ:ALKS) Shares Gap UpHere's What Happened - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

Alkermes raised to buy by Stifel on increased confidence for ALKS2680 (NASDAQ:ALKS) - Seeking Alpha

Nov 05, 2024
pulisher
Nov 05, 2024

Alkermes PLC (ALKS) Shares Up 5.57% on Nov 5 - GuruFocus.com

Nov 05, 2024
pulisher
Nov 05, 2024

Alkermes (NASDAQ:ALKS) Upgraded to Buy at Stifel Nicolaus - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

A Glimpse Into The Expert Outlook On Alkermes Through 9 Analysts - Benzinga

Nov 05, 2024
pulisher
Nov 05, 2024

Stifel raises Alkermes target to $36, upgrades to buy By Investing.com - Investing.com Australia

Nov 05, 2024
pulisher
Nov 04, 2024

Stifel raises Alkermes target to $36, upgrades to buy - Investing.com India

Nov 04, 2024
pulisher
Nov 04, 2024

Alkermes plc (NASDAQ:ALKS) Holdings Decreased by DekaBank Deutsche Girozentrale - MarketBeat

Nov 04, 2024
pulisher
Oct 30, 2024

(ALKS) Proactive Strategies - Stock Traders Daily

Oct 30, 2024
pulisher
Oct 30, 2024

Short Interest in Alkermes plc (NASDAQ:ALKS) Drops By 7.9% - MarketBeat

Oct 30, 2024
pulisher
Oct 29, 2024

Alkermes plc (NASDAQ:ALKS) Shares Sold by Allspring Global Investments Holdings LLC - MarketBeat

Oct 29, 2024
pulisher
Oct 29, 2024

Alkermes holds steady stock target with neutral rating amid royalty segment dip - Investing.com

Oct 29, 2024
pulisher
Oct 28, 2024

Alkermes holds steady stock target with neutral rating amid royalty segment dip By Investing.com - Investing.com South Africa

Oct 28, 2024
pulisher
Oct 28, 2024

Alkermes's SWOT analysis: innovative pipeline drives CNS stock's future - Investing.com

Oct 28, 2024
pulisher
Oct 28, 2024

Alkermes Eyes Completion of Phase 2 Narcolepsy Studies in 2025 - Sleep Review

Oct 28, 2024
pulisher
Oct 26, 2024

Goldman Sachs keeps Alkermes stock buy-rated ahead of milestone readouts, trims PT - Investing.com Canada

Oct 26, 2024
pulisher
Oct 25, 2024

Piper Sandler cuts Alkermes stock target, keeps Overweight rating By Investing.com - Investing.com Australia

Oct 25, 2024
pulisher
Oct 25, 2024

Leerink maintains Alkermes stock rating with $28 target amid financial projections - Investing.com Australia

Oct 25, 2024
pulisher
Oct 25, 2024

Leerink maintains Alkermes stock rating with $28 target amid financial projections By Investing.com - Investing.com South Africa

Oct 25, 2024
pulisher
Oct 25, 2024

Alkermes (NASDAQ:ALKS) PT Lowered to $30.00 - MarketBeat

Oct 25, 2024
pulisher
Oct 25, 2024

Piper Sandler cuts Alkermes stock target, keeps Overweight rating - Investing.com

Oct 25, 2024
pulisher
Oct 25, 2024

Alkermes' Q3 Earnings & Revenues Fall Shy of Estimates, Stock Down - MSN

Oct 25, 2024
pulisher
Oct 25, 2024

Alkermes' Q3 Earnings & Revenues Fall Shy Of Estimates, Stock Down - Barchart

Oct 25, 2024
pulisher
Oct 25, 2024

Alkermes' (ALKS) Overweight Rating Reiterated at Piper Sandler - MarketBeat

Oct 25, 2024
pulisher
Oct 25, 2024

Alkermes plc (NASDAQ:ALKS) Q3 2024 Earnings Call Transcript - Insider Monkey

Oct 25, 2024
pulisher
Oct 25, 2024

Earnings call: Alkermes Plc reports solid Q3 growth, eyes future expansion - Investing.com

Oct 25, 2024

Alkermes Plc Azioni (ALKS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$87.32
price up icon 1.01%
$13.40
price down icon 0.30%
$85.45
price down icon 0.22%
$59.66
price up icon 1.12%
$125.00
price up icon 1.39%
$13.25
price up icon 0.91%
Capitalizzazione:     |  Volume (24 ore):